A comparison of the safety and efficacy of oral antiocoagulation for the treatment of venous thromboembolic disease in patients with or without malignancy

G. Palareti, C. Legnani, A. Lee, C. Manotti, J. Hirsh, A. D'Angelo, V. Pengo, M. Moia, S. Coccheri

Research output: Contribution to journalArticle

Abstract

The optimal long-term treatment of acute venous thromboembolism (VTE) in patients with malignancy remains undefined. In particular, based on current e vidence, it is uncertain whether secondary prophylaxis using standard intensity oral anticoagulant therapy is associated with higher risks of bleeding and recurrent thrombosis in patients with cancer than in those without cancer. This study compared with outcome of anticoagulation corses in 95 patien ts with malignancy with those of 733 patients with malignancy. All patients were participants in a large, nation-wide population study and were prospe ctively followed from the initiation of their oral anticoagulation therapy. Based on 744 patient-years of treatment and follow-up, the rates of major (5.4% vs0.9%) minor (16.2% vs 3.6%) and total (21.6% vs 4.5%) bleeding were statistically significantly higher in cancer patients compared with patien ts without cancer. Bleeding was also a more frequent cause of early anticoagulation withdrawal in patients with malignancy (4.2% vs. 0.7%;

Original languageEnglish
Pages (from-to)805-810
Number of pages6
JournalThrombosis and Haemostasis
Volume84
Issue number5
Publication statusPublished - 2000

Fingerprint

Safety
Neoplasms
Therapeutics
Hemorrhage
Venous Thromboembolism
Anticoagulants
Thrombosis
Population

Keywords

  • Cancer
  • DVT
  • Oral anticoagulation
  • Safety

ASJC Scopus subject areas

  • Hematology

Cite this

A comparison of the safety and efficacy of oral antiocoagulation for the treatment of venous thromboembolic disease in patients with or without malignancy. / Palareti, G.; Legnani, C.; Lee, A.; Manotti, C.; Hirsh, J.; D'Angelo, A.; Pengo, V.; Moia, M.; Coccheri, S.

In: Thrombosis and Haemostasis, Vol. 84, No. 5, 2000, p. 805-810.

Research output: Contribution to journalArticle

@article{de6db5f940164fe1805638c1521777c8,
title = "A comparison of the safety and efficacy of oral antiocoagulation for the treatment of venous thromboembolic disease in patients with or without malignancy",
abstract = "The optimal long-term treatment of acute venous thromboembolism (VTE) in patients with malignancy remains undefined. In particular, based on current e vidence, it is uncertain whether secondary prophylaxis using standard intensity oral anticoagulant therapy is associated with higher risks of bleeding and recurrent thrombosis in patients with cancer than in those without cancer. This study compared with outcome of anticoagulation corses in 95 patien ts with malignancy with those of 733 patients with malignancy. All patients were participants in a large, nation-wide population study and were prospe ctively followed from the initiation of their oral anticoagulation therapy. Based on 744 patient-years of treatment and follow-up, the rates of major (5.4{\%} vs0.9{\%}) minor (16.2{\%} vs 3.6{\%}) and total (21.6{\%} vs 4.5{\%}) bleeding were statistically significantly higher in cancer patients compared with patien ts without cancer. Bleeding was also a more frequent cause of early anticoagulation withdrawal in patients with malignancy (4.2{\%} vs. 0.7{\%};",
keywords = "Cancer, DVT, Oral anticoagulation, Safety",
author = "G. Palareti and C. Legnani and A. Lee and C. Manotti and J. Hirsh and A. D'Angelo and V. Pengo and M. Moia and S. Coccheri",
year = "2000",
language = "English",
volume = "84",
pages = "805--810",
journal = "Thrombosis and Haemostasis",
issn = "0340-6245",
publisher = "Schattauer GmbH",
number = "5",

}

TY - JOUR

T1 - A comparison of the safety and efficacy of oral antiocoagulation for the treatment of venous thromboembolic disease in patients with or without malignancy

AU - Palareti, G.

AU - Legnani, C.

AU - Lee, A.

AU - Manotti, C.

AU - Hirsh, J.

AU - D'Angelo, A.

AU - Pengo, V.

AU - Moia, M.

AU - Coccheri, S.

PY - 2000

Y1 - 2000

N2 - The optimal long-term treatment of acute venous thromboembolism (VTE) in patients with malignancy remains undefined. In particular, based on current e vidence, it is uncertain whether secondary prophylaxis using standard intensity oral anticoagulant therapy is associated with higher risks of bleeding and recurrent thrombosis in patients with cancer than in those without cancer. This study compared with outcome of anticoagulation corses in 95 patien ts with malignancy with those of 733 patients with malignancy. All patients were participants in a large, nation-wide population study and were prospe ctively followed from the initiation of their oral anticoagulation therapy. Based on 744 patient-years of treatment and follow-up, the rates of major (5.4% vs0.9%) minor (16.2% vs 3.6%) and total (21.6% vs 4.5%) bleeding were statistically significantly higher in cancer patients compared with patien ts without cancer. Bleeding was also a more frequent cause of early anticoagulation withdrawal in patients with malignancy (4.2% vs. 0.7%;

AB - The optimal long-term treatment of acute venous thromboembolism (VTE) in patients with malignancy remains undefined. In particular, based on current e vidence, it is uncertain whether secondary prophylaxis using standard intensity oral anticoagulant therapy is associated with higher risks of bleeding and recurrent thrombosis in patients with cancer than in those without cancer. This study compared with outcome of anticoagulation corses in 95 patien ts with malignancy with those of 733 patients with malignancy. All patients were participants in a large, nation-wide population study and were prospe ctively followed from the initiation of their oral anticoagulation therapy. Based on 744 patient-years of treatment and follow-up, the rates of major (5.4% vs0.9%) minor (16.2% vs 3.6%) and total (21.6% vs 4.5%) bleeding were statistically significantly higher in cancer patients compared with patien ts without cancer. Bleeding was also a more frequent cause of early anticoagulation withdrawal in patients with malignancy (4.2% vs. 0.7%;

KW - Cancer

KW - DVT

KW - Oral anticoagulation

KW - Safety

UR - http://www.scopus.com/inward/record.url?scp=0033708930&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033708930&partnerID=8YFLogxK

M3 - Article

C2 - 11127860

AN - SCOPUS:0033708930

VL - 84

SP - 805

EP - 810

JO - Thrombosis and Haemostasis

JF - Thrombosis and Haemostasis

SN - 0340-6245

IS - 5

ER -